nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP3A4—Temozolomide—malignant glioma	0.313	1	CbGbCtD
Guanfacine—Paresis—Temozolomide—malignant glioma	0.0277	0.061	CcSEcCtD
Guanfacine—Hypokinesia—Carmustine—malignant glioma	0.0155	0.0341	CcSEcCtD
Guanfacine—Diclofenac—CYP2C18—malignant glioma	0.0105	0.288	CrCbGaD
Guanfacine—Urinary incontinence—Carmustine—malignant glioma	0.0101	0.0222	CcSEcCtD
Guanfacine—Diclofenac—CXCL8—malignant glioma	0.0101	0.276	CrCbGaD
Guanfacine—Skin exfoliation—Carmustine—malignant glioma	0.01	0.022	CcSEcCtD
Guanfacine—Urinary incontinence—Temozolomide—malignant glioma	0.00978	0.0215	CcSEcCtD
Guanfacine—Skin exfoliation—Temozolomide—malignant glioma	0.00967	0.0213	CcSEcCtD
Guanfacine—Vascular purpura—Temozolomide—malignant glioma	0.00822	0.0181	CcSEcCtD
Guanfacine—Amnesia—Carmustine—malignant glioma	0.00809	0.0178	CcSEcCtD
Guanfacine—Amnesia—Temozolomide—malignant glioma	0.00782	0.0172	CcSEcCtD
Guanfacine—Diclofenac—CYP2B6—malignant glioma	0.0078	0.214	CrCbGaD
Guanfacine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00779	0.0171	CcSEcCtD
Guanfacine—Purpura—Temozolomide—malignant glioma	0.00763	0.0168	CcSEcCtD
Guanfacine—Affect lability—Temozolomide—malignant glioma	0.00723	0.0159	CcSEcCtD
Guanfacine—Liver function test abnormal—Carmustine—malignant glioma	0.00702	0.0154	CcSEcCtD
Guanfacine—Dysphagia—Carmustine—malignant glioma	0.00657	0.0145	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00648	0.0143	CcSEcCtD
Guanfacine—Dysphagia—Temozolomide—malignant glioma	0.00635	0.014	CcSEcCtD
Guanfacine—Pollakiuria—Temozolomide—malignant glioma	0.00587	0.0129	CcSEcCtD
Guanfacine—Erectile dysfunction—Temozolomide—malignant glioma	0.00585	0.0129	CcSEcCtD
Guanfacine—Weight increased—Temozolomide—malignant glioma	0.00578	0.0127	CcSEcCtD
Guanfacine—Hallucination—Carmustine—malignant glioma	0.00523	0.0115	CcSEcCtD
Guanfacine—Diclofenac—PTGS1—malignant glioma	0.00513	0.141	CrCbGaD
Guanfacine—Visual impairment—Carmustine—malignant glioma	0.00507	0.0111	CcSEcCtD
Guanfacine—Hallucination—Temozolomide—malignant glioma	0.00506	0.0111	CcSEcCtD
Guanfacine—Eye disorder—Carmustine—malignant glioma	0.00492	0.0108	CcSEcCtD
Guanfacine—Visual impairment—Temozolomide—malignant glioma	0.0049	0.0108	CcSEcCtD
Guanfacine—Eye disorder—Temozolomide—malignant glioma	0.00475	0.0104	CcSEcCtD
Guanfacine—Tinnitus—Temozolomide—malignant glioma	0.00474	0.0104	CcSEcCtD
Guanfacine—Alopecia—Carmustine—malignant glioma	0.00465	0.0102	CcSEcCtD
Guanfacine—Immune system disorder—Temozolomide—malignant glioma	0.00459	0.0101	CcSEcCtD
Guanfacine—Alopecia—Temozolomide—malignant glioma	0.00449	0.00988	CcSEcCtD
Guanfacine—Dysgeusia—Temozolomide—malignant glioma	0.00433	0.00953	CcSEcCtD
Guanfacine—Vision blurred—Carmustine—malignant glioma	0.00432	0.00949	CcSEcCtD
Guanfacine—Tremor—Carmustine—malignant glioma	0.00429	0.00944	CcSEcCtD
Guanfacine—Agitation—Carmustine—malignant glioma	0.00421	0.00926	CcSEcCtD
Guanfacine—Vision blurred—Temozolomide—malignant glioma	0.00417	0.00917	CcSEcCtD
Guanfacine—Tremor—Temozolomide—malignant glioma	0.00415	0.00912	CcSEcCtD
Guanfacine—Ill-defined disorder—Temozolomide—malignant glioma	0.00411	0.00903	CcSEcCtD
Guanfacine—Agitation—Temozolomide—malignant glioma	0.00407	0.00894	CcSEcCtD
Guanfacine—Malaise—Temozolomide—malignant glioma	0.00399	0.00878	CcSEcCtD
Guanfacine—Vertigo—Temozolomide—malignant glioma	0.00398	0.00874	CcSEcCtD
Guanfacine—Convulsion—Carmustine—malignant glioma	0.00397	0.00873	CcSEcCtD
Guanfacine—Hypertension—Carmustine—malignant glioma	0.00395	0.0087	CcSEcCtD
Guanfacine—Palpitations—Temozolomide—malignant glioma	0.00391	0.0086	CcSEcCtD
Guanfacine—Chest pain—Carmustine—malignant glioma	0.0039	0.00857	CcSEcCtD
Guanfacine—Myalgia—Carmustine—malignant glioma	0.0039	0.00857	CcSEcCtD
Guanfacine—Anxiety—Carmustine—malignant glioma	0.00389	0.00854	CcSEcCtD
Guanfacine—Convulsion—Temozolomide—malignant glioma	0.00383	0.00843	CcSEcCtD
Guanfacine—Hypertension—Temozolomide—malignant glioma	0.00382	0.0084	CcSEcCtD
Guanfacine—Confusional state—Carmustine—malignant glioma	0.00377	0.00829	CcSEcCtD
Guanfacine—Arthralgia—Temozolomide—malignant glioma	0.00377	0.00829	CcSEcCtD
Guanfacine—Myalgia—Temozolomide—malignant glioma	0.00377	0.00829	CcSEcCtD
Guanfacine—Anxiety—Temozolomide—malignant glioma	0.00375	0.00826	CcSEcCtD
Guanfacine—Oedema—Carmustine—malignant glioma	0.00374	0.00822	CcSEcCtD
Guanfacine—Discomfort—Temozolomide—malignant glioma	0.00372	0.00819	CcSEcCtD
Guanfacine—Dry mouth—Temozolomide—malignant glioma	0.00369	0.0081	CcSEcCtD
Guanfacine—Tachycardia—Carmustine—malignant glioma	0.00365	0.00802	CcSEcCtD
Guanfacine—Confusional state—Temozolomide—malignant glioma	0.00364	0.00801	CcSEcCtD
Guanfacine—Oedema—Temozolomide—malignant glioma	0.00361	0.00794	CcSEcCtD
Guanfacine—Hypotension—Carmustine—malignant glioma	0.00349	0.00768	CcSEcCtD
Guanfacine—Hyperhidrosis—Temozolomide—malignant glioma	0.00349	0.00768	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00341	0.00749	CcSEcCtD
Guanfacine—Insomnia—Carmustine—malignant glioma	0.00338	0.00743	CcSEcCtD
Guanfacine—Paraesthesia—Carmustine—malignant glioma	0.00336	0.00738	CcSEcCtD
Guanfacine—Dyspnoea—Carmustine—malignant glioma	0.00333	0.00733	CcSEcCtD
Guanfacine—Somnolence—Carmustine—malignant glioma	0.00332	0.00731	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00329	0.00724	CcSEcCtD
Guanfacine—Insomnia—Temozolomide—malignant glioma	0.00327	0.00718	CcSEcCtD
Guanfacine—Decreased appetite—Carmustine—malignant glioma	0.00325	0.00715	CcSEcCtD
Guanfacine—Paraesthesia—Temozolomide—malignant glioma	0.00324	0.00713	CcSEcCtD
Guanfacine—Dyspnoea—Temozolomide—malignant glioma	0.00322	0.00708	CcSEcCtD
Guanfacine—Somnolence—Temozolomide—malignant glioma	0.00321	0.00706	CcSEcCtD
Guanfacine—Constipation—Carmustine—malignant glioma	0.0032	0.00703	CcSEcCtD
Guanfacine—Dyspepsia—Temozolomide—malignant glioma	0.00318	0.00699	CcSEcCtD
Guanfacine—Decreased appetite—Temozolomide—malignant glioma	0.00314	0.0069	CcSEcCtD
Guanfacine—Fatigue—Temozolomide—malignant glioma	0.00311	0.00685	CcSEcCtD
Guanfacine—Constipation—Temozolomide—malignant glioma	0.00309	0.00679	CcSEcCtD
Guanfacine—Feeling abnormal—Carmustine—malignant glioma	0.00308	0.00677	CcSEcCtD
Guanfacine—Gastrointestinal pain—Carmustine—malignant glioma	0.00306	0.00672	CcSEcCtD
Guanfacine—Feeling abnormal—Temozolomide—malignant glioma	0.00298	0.00655	CcSEcCtD
Guanfacine—Abdominal pain—Carmustine—malignant glioma	0.00295	0.0065	CcSEcCtD
Guanfacine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00295	0.0065	CcSEcCtD
Guanfacine—Diclofenac—PTGS2—malignant glioma	0.00293	0.0805	CrCbGaD
Guanfacine—Abdominal pain—Temozolomide—malignant glioma	0.00286	0.00628	CcSEcCtD
Guanfacine—Hypersensitivity—Carmustine—malignant glioma	0.00275	0.00606	CcSEcCtD
Guanfacine—Asthenia—Carmustine—malignant glioma	0.00268	0.0059	CcSEcCtD
Guanfacine—Hypersensitivity—Temozolomide—malignant glioma	0.00266	0.00585	CcSEcCtD
Guanfacine—Asthenia—Temozolomide—malignant glioma	0.00259	0.0057	CcSEcCtD
Guanfacine—Diarrhoea—Carmustine—malignant glioma	0.00256	0.00562	CcSEcCtD
Guanfacine—Pruritus—Temozolomide—malignant glioma	0.00256	0.00562	CcSEcCtD
Guanfacine—Dizziness—Carmustine—malignant glioma	0.00247	0.00544	CcSEcCtD
Guanfacine—Diarrhoea—Temozolomide—malignant glioma	0.00247	0.00543	CcSEcCtD
Guanfacine—Dizziness—Temozolomide—malignant glioma	0.00239	0.00525	CcSEcCtD
Guanfacine—Vomiting—Carmustine—malignant glioma	0.00238	0.00523	CcSEcCtD
Guanfacine—Rash—Carmustine—malignant glioma	0.00236	0.00518	CcSEcCtD
Guanfacine—Dermatitis—Carmustine—malignant glioma	0.00235	0.00518	CcSEcCtD
Guanfacine—Headache—Carmustine—malignant glioma	0.00234	0.00515	CcSEcCtD
Guanfacine—Vomiting—Temozolomide—malignant glioma	0.0023	0.00505	CcSEcCtD
Guanfacine—Rash—Temozolomide—malignant glioma	0.00228	0.00501	CcSEcCtD
Guanfacine—Dermatitis—Temozolomide—malignant glioma	0.00228	0.005	CcSEcCtD
Guanfacine—Headache—Temozolomide—malignant glioma	0.00226	0.00498	CcSEcCtD
Guanfacine—Nausea—Carmustine—malignant glioma	0.00222	0.00488	CcSEcCtD
Guanfacine—Nausea—Temozolomide—malignant glioma	0.00215	0.00472	CcSEcCtD
Guanfacine—ADRA2B—Signaling by GPCR—F2—malignant glioma	9.52e-05	0.000486	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2B6—malignant glioma	9.51e-05	0.000486	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—VEGFA—malignant glioma	9.5e-05	0.000485	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—JAG2—malignant glioma	9.47e-05	0.000484	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—RAF1—malignant glioma	9.46e-05	0.000483	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SPHK1—malignant glioma	9.23e-05	0.000472	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—PIK3CB—malignant glioma	9.23e-05	0.000471	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT2—malignant glioma	9.18e-05	0.000469	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CG—malignant glioma	9.11e-05	0.000465	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP2C18—malignant glioma	9.05e-05	0.000462	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—BCHE—malignant glioma	9e-05	0.00046	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PTPN11—malignant glioma	8.95e-05	0.000457	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—malignant glioma	8.92e-05	0.000456	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOTCH2—malignant glioma	8.89e-05	0.000454	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—SLC5A5—malignant glioma	8.89e-05	0.000454	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PIK3CD—malignant glioma	8.82e-05	0.000451	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ASMT—malignant glioma	8.81e-05	0.00045	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KNG1—malignant glioma	8.7e-05	0.000445	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—IDH1—malignant glioma	8.7e-05	0.000444	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.53e-05	0.000436	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—IL2—malignant glioma	8.48e-05	0.000433	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SPHK1—malignant glioma	8.42e-05	0.00043	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT2—malignant glioma	8.34e-05	0.000426	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NTRK1—malignant glioma	8.29e-05	0.000424	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—BCAN—malignant glioma	8.28e-05	0.000423	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2C18—malignant glioma	8.25e-05	0.000421	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—KRAS—malignant glioma	8.07e-05	0.000412	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—H3F3A—malignant glioma	8.01e-05	0.000409	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CD—malignant glioma	8.01e-05	0.000409	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—F2—malignant glioma	7.96e-05	0.000406	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCR3—malignant glioma	7.94e-05	0.000405	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.78e-05	0.000397	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.77e-05	0.000397	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—YWHAE—malignant glioma	7.72e-05	0.000394	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NTRK2—malignant glioma	7.72e-05	0.000394	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP3—malignant glioma	7.71e-05	0.000394	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PIK3CB—malignant glioma	7.69e-05	0.000393	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FLT1—malignant glioma	7.69e-05	0.000393	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—DUSP6—malignant glioma	7.65e-05	0.000391	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDKN2B—malignant glioma	7.64e-05	0.00039	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CG—malignant glioma	7.61e-05	0.000389	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—JAG1—malignant glioma	7.55e-05	0.000386	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH3—malignant glioma	7.52e-05	0.000384	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.5e-05	0.000383	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTK2—malignant glioma	7.42e-05	0.000379	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—PIK3CA—malignant glioma	7.42e-05	0.000379	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FBXW7—malignant glioma	7.4e-05	0.000378	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CXCL8—malignant glioma	7.39e-05	0.000377	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTT1—malignant glioma	7.32e-05	0.000374	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HES1—malignant glioma	7.29e-05	0.000372	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—BDKRB2—malignant glioma	7.26e-05	0.000371	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NCOR1—malignant glioma	7.25e-05	0.00037	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—F2—malignant glioma	7.22e-05	0.000369	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—VEGFA—malignant glioma	7.2e-05	0.000368	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—TP53—malignant glioma	7.18e-05	0.000366	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GSTP1—malignant glioma	7.16e-05	0.000366	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—RAF1—malignant glioma	7.15e-05	0.000365	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.09e-05	0.000362	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—IL2—malignant glioma	7.06e-05	0.000361	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CB—malignant glioma	6.98e-05	0.000357	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT2—malignant glioma	6.97e-05	0.000356	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CAT—malignant glioma	6.97e-05	0.000356	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PDGFRA—malignant glioma	6.94e-05	0.000355	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CG—malignant glioma	6.91e-05	0.000353	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS1—malignant glioma	6.86e-05	0.00035	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.84e-05	0.000349	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.83e-05	0.000349	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PTPN11—malignant glioma	6.79e-05	0.000347	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH2—malignant glioma	6.75e-05	0.000345	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SPP1—malignant glioma	6.74e-05	0.000344	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CXCL8—malignant glioma	6.71e-05	0.000343	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CD—malignant glioma	6.69e-05	0.000342	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—IDH2—malignant glioma	6.67e-05	0.000341	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTT1—malignant glioma	6.67e-05	0.000341	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KNG1—malignant glioma	6.6e-05	0.000337	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NCOR1—malignant glioma	6.58e-05	0.000336	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL2—malignant glioma	6.41e-05	0.000328	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TERT—malignant glioma	6.39e-05	0.000326	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—BCHE—malignant glioma	6.37e-05	0.000326	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT2—malignant glioma	6.33e-05	0.000323	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SLC5A5—malignant glioma	6.3e-05	0.000322	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NTRK1—malignant glioma	6.29e-05	0.000321	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.27e-05	0.00032	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS1—malignant glioma	6.25e-05	0.000319	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PDGFB—malignant glioma	6.24e-05	0.000319	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.23e-05	0.000318	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGFR1—malignant glioma	6.2e-05	0.000317	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—KRAS—malignant glioma	6.13e-05	0.000313	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HIF1A—malignant glioma	6.11e-05	0.000312	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CD—malignant glioma	6.08e-05	0.00031	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—AKT1—malignant glioma	6.06e-05	0.000309	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.95e-05	0.000304	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CAV1—malignant glioma	5.91e-05	0.000302	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.9e-05	0.000301	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP3—malignant glioma	5.85e-05	0.000299	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KDR—malignant glioma	5.84e-05	0.000298	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CB—malignant glioma	5.83e-05	0.000298	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—BCHE—malignant glioma	5.81e-05	0.000297	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN2B—malignant glioma	5.8e-05	0.000296	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC5A5—malignant glioma	5.74e-05	0.000293	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—IDH1—malignant glioma	5.74e-05	0.000293	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTK2—malignant glioma	5.63e-05	0.000288	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—PIK3CA—malignant glioma	5.63e-05	0.000287	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—F2—malignant glioma	5.63e-05	0.000287	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FN1—malignant glioma	5.63e-05	0.000287	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCL8—malignant glioma	5.61e-05	0.000286	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—BAD—malignant glioma	5.56e-05	0.000284	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SPHK1—malignant glioma	5.55e-05	0.000284	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HES1—malignant glioma	5.53e-05	0.000283	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOTCH1—malignant glioma	5.5e-05	0.000281	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NCOR1—malignant glioma	5.5e-05	0.000281	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TP53—malignant glioma	5.44e-05	0.000278	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.44e-05	0.000278	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.43e-05	0.000277	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—RAF1—malignant glioma	5.43e-05	0.000277	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CD80—malignant glioma	5.39e-05	0.000275	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APC—malignant glioma	5.38e-05	0.000275	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CG—malignant glioma	5.38e-05	0.000275	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.38e-05	0.000275	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CAV1—malignant glioma	5.36e-05	0.000274	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—IL2—malignant glioma	5.36e-05	0.000274	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGF—malignant glioma	5.32e-05	0.000272	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CB—malignant glioma	5.3e-05	0.000271	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTPN11—malignant glioma	5.29e-05	0.00027	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PDGFRA—malignant glioma	5.27e-05	0.000269	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.14e-05	0.000263	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SPP1—malignant glioma	5.11e-05	0.000261	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL8—malignant glioma	5.09e-05	0.00026	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTP1—malignant glioma	5.07e-05	0.000259	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—BRAF—malignant glioma	5.06e-05	0.000258	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAT—malignant glioma	4.93e-05	0.000252	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT2—malignant glioma	4.93e-05	0.000252	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—EGFR—malignant glioma	4.9e-05	0.00025	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CG—malignant glioma	4.88e-05	0.000249	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL2—malignant glioma	4.87e-05	0.000249	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TERT—malignant glioma	4.85e-05	0.000248	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CD—malignant glioma	4.73e-05	0.000242	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PDGFB—malignant glioma	4.73e-05	0.000242	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARG—malignant glioma	4.71e-05	0.000241	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGFR1—malignant glioma	4.71e-05	0.00024	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.69e-05	0.00024	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PIK3CA—malignant glioma	4.69e-05	0.000239	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NCOR1—malignant glioma	4.66e-05	0.000238	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HIF1A—malignant glioma	4.64e-05	0.000237	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—KRAS—malignant glioma	4.63e-05	0.000237	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTP1—malignant glioma	4.62e-05	0.000236	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—malignant glioma	4.6e-05	0.000235	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGF2—malignant glioma	4.53e-05	0.000231	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAT—malignant glioma	4.5e-05	0.00023	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CAV1—malignant glioma	4.48e-05	0.000229	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KDR—malignant glioma	4.43e-05	0.000226	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTT1—malignant glioma	4.4e-05	0.000225	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CD—malignant glioma	4.29e-05	0.000219	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FN1—malignant glioma	4.27e-05	0.000218	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—F2—malignant glioma	4.27e-05	0.000218	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CA—malignant glioma	4.26e-05	0.000217	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NCOR1—malignant glioma	4.25e-05	0.000217	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MDM2—malignant glioma	4.24e-05	0.000217	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RAF1—malignant glioma	4.22e-05	0.000216	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—BAD—malignant glioma	4.22e-05	0.000215	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ERBB2—malignant glioma	4.18e-05	0.000213	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	4.18e-05	0.000213	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CB—malignant glioma	4.12e-05	0.000211	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS1—malignant glioma	4.12e-05	0.000211	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CD80—malignant glioma	4.09e-05	0.000209	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APC—malignant glioma	4.08e-05	0.000209	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	4.08e-05	0.000209	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGF—malignant glioma	4.04e-05	0.000206	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	4.01e-05	0.000205	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	3.96e-05	0.000202	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—BRAF—malignant glioma	3.84e-05	0.000196	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—BCHE—malignant glioma	3.83e-05	0.000196	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	3.83e-05	0.000196	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAV1—malignant glioma	3.8e-05	0.000194	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CASP3—malignant glioma	3.79e-05	0.000194	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL2—malignant glioma	3.79e-05	0.000193	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.79e-05	0.000193	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CB—malignant glioma	3.74e-05	0.000191	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT2—malignant glioma	3.74e-05	0.000191	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	3.72e-05	0.00019	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—malignant glioma	3.71e-05	0.000189	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.63e-05	0.000185	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	3.59e-05	0.000183	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—malignant glioma	3.59e-05	0.000183	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTEN—malignant glioma	3.56e-05	0.000182	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.56e-05	0.000182	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	3.52e-05	0.00018	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	3.48e-05	0.000178	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAV1—malignant glioma	3.46e-05	0.000177	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.46e-05	0.000177	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	3.44e-05	0.000176	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARG—malignant glioma	3.34e-05	0.000171	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.31e-05	0.000169	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTEN—malignant glioma	3.23e-05	0.000165	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	3.23e-05	0.000165	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	3.22e-05	0.000164	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	3.22e-05	0.000164	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	3.21e-05	0.000164	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	3.19e-05	0.000163	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	3.17e-05	0.000162	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.16e-05	0.000161	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	3.13e-05	0.00016	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTP1—malignant glioma	3.05e-05	0.000156	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARG—malignant glioma	3.05e-05	0.000156	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.04e-05	0.000155	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	3.01e-05	0.000154	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAT—malignant glioma	2.97e-05	0.000152	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MYC—malignant glioma	2.96e-05	0.000151	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	2.91e-05	0.000148	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	2.9e-05	0.000148	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	2.88e-05	0.000147	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL2—malignant glioma	2.87e-05	0.000147	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NCOR1—malignant glioma	2.8e-05	0.000143	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.77e-05	0.000142	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	2.74e-05	0.00014	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	2.72e-05	0.000139	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	2.7e-05	0.000138	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.65e-05	0.000135	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	2.64e-05	0.000135	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—malignant glioma	2.63e-05	0.000134	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	2.51e-05	0.000128	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	2.44e-05	0.000125	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TP53—malignant glioma	2.43e-05	0.000124	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	2.42e-05	0.000124	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.42e-05	0.000123	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—malignant glioma	2.4e-05	0.000122	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTEN—malignant glioma	2.29e-05	0.000117	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAV1—malignant glioma	2.28e-05	0.000117	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CA—malignant glioma	2.28e-05	0.000117	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MYC—malignant glioma	2.25e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	2.2e-05	0.000112	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTEN—malignant glioma	2.09e-05	0.000107	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.08e-05	0.000106	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	2.08e-05	0.000106	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	2.05e-05	0.000105	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARG—malignant glioma	2.01e-05	0.000103	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.91e-05	9.74e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—malignant glioma	1.86e-05	9.52e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.85e-05	9.43e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.83e-05	9.34e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.62e-05	8.26e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.59e-05	8.14e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.58e-05	8.07e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	1.56e-05	7.96e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.47e-05	7.53e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTEN—malignant glioma	1.38e-05	7.04e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—malignant glioma	1.32e-05	6.74e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—malignant glioma	1.2e-05	6.15e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CA—malignant glioma	9.72e-06	4.96e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—malignant glioma	7.94e-06	4.06e-05	CbGpPWpGaD
